Bruno Carlos
Sangro Gómez-Acebo
Catedrático de Universidad
Toronto General Hospital
Toronto, CanadáPublicacions en col·laboració amb investigadors/es de Toronto General Hospital (4)
2024
-
Evidence and choice: The BCLC vision for tailoring clinical decision-making
Journal of Hepatology
-
Patient-Reported Outcomes from the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma
Journal of Clinical Oncology, Vol. 42, Núm. 23, pp. 2790-2799
2021
-
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
JHEP Reports, Vol. 3, Núm. 3
2020
-
Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference
Transplantation, Vol. 104, Núm. 6, pp. 1143-1149